Voyager CEO Resigns After Company Turns Back To Discovery-Stage

0
147

  • Voyager Therapeutics, Inc (NASDAQ: VYGR) CEO and President Andre Turenne will step down as the beleaguered company announced it would move focus to early, discovery-stage efforts.
  • The company’s CMO and R&D chief, Omar Khwaja, also stepped down after two years at the biotech.
  • Voyager said that Turenne would leave to “pursue other opportunities,” and Khwaja found a new opportunity in Europe.
  • Accordingly, the company …

Full story available on Benzinga.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here